Details of the Drug Inactive Ingredient (DIG)

General Information of DIG (ID: E07WLC)
DIG Name	Sodium ascorbate
Synonyms	Click to Show/Hide the Synonyms of This DIG SODIUM ASCORBATE; L-Ascorbic acid sodium salt; 134-03-2; Sodium L-ascorbate; Vitamin C sodium; Ascorbic acid sodium salt; Monosodium L-ascorbate; Ascorbicin; Sodascorbate; Natrii ascorbas; Vitamin C, sodium salt; ascorbate; Ascorbate de sodium; L-Ascorbic acid, monosodium salt; Ascorbin; MFCD00082340; UNII-S033EH8359; L(+)-Ascorbic acid sodium salt; Vitamin C Sodium Salt; (+)-Sodium L-ascorbate; Sodium (R)-2-((S)-1,2-dihydroxyethyl)-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate; S033EH8359; Cebitate; Aminofenitrooxon; sodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate; Iskia-C; Natri-C; sodium (L)-ascorbate; sodiumascorbate; C6H7NaO6; Ascorbato sodico; Ascorbato sodico [DCIT]; sodium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate; Natrii ascorbas [INN-Latin]; Ascorbic acid sodium derivative; CCRIS 3291; HSDB 694; 3-Oxo-L-gulofuranolactone sodium; HBL 508; L-Ascorbic acid sodium; Ascorbate de sodium [INN-French]; EINECS 205-126-1; Tianafacacid; Sodium ascorbate [USP:INN]; L-Ascorbic acid, sodium salt (1:1); Sodium derivative of 3-oxo-L-gulofuranolactone; ascorbic acid sodium; E301; sodium L-ascorbate salt; DSSTox_CID_105; 58657-35-5; EC 205-126-1; SCHEMBL3745; DSSTox_RID_75369; DSSTox_GSID_20105; L(+)Ascorbic acid sodium salt; CHEMBL591665; INS NO.301; DTXSID0020105; HY-B0166A; INS-301; CHEBI:113451; L-Ascorbic Acid Sodium Salt,(S); L-Ascorbic Acid - Monosodium Salt; Tox21_300556; AKOS015895058; CS-6063; DB14482; sodium (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2,5-dihydrofuran-3-olate; NCGC00254355-01; BP-30077; CAS-134-03-2; M609; A0539; B1834; E-301; A806721; Q424551; J-006471; sodium (2R)-2-[(1S)-1,2-bis(oxidanyl)ethyl]-4-oxidanyl-5-oxidanylidene-2H-furan-3-olate
DIG Function	Antioxidant
PubChem CID	23667548
Formula	C6H7NaO6
Canonical SMILES	C([C@@H]([C@@H]1C(=C(C(=O)O1)O)[O-])O)O.[Na+]
InChI	1S/C6H8O6.Na/c7-1-2(8)5-3(9)4(10)6(11)12-5;/h2,5,7-10H,1H2;/q;+1/p-1/t2-,5+;/m0./s1
InChIKey	PPASLZSBLFJQEF-RXSVEWSESA-M
	Click to Show/Hide the Molecular Data (Structure/Property) of This DIG
Structure	<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=23667548"></iframe>
Structure	3D MOL is not available		2D MOL
Physicochemical Properties	Molecular Weight	198.11	Topological Polar Surface Area	110
	XlogP	N.A.	Complexity	237
	Heavy Atom Count	13	Rotatable Bond Count	2
	Hydrogen Bond Donor Count	3	Hydrogen Bond Acceptor Count	6

Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG
ICD Disease Classification 01		Infectious/parasitic disease	Click to Show/Hide
Rifapentine	API Info	Pulmonary tuberculosis [ICD-11: 1B10]		[1]
ICD Disease Classification 14		Skin disease	Click to Show/Hide
Acitretin	API Info	Psoriasis vulgaris [ICD-11: EA90]		[2]

References
1	FDA label for approved rifapentine from the official website of the U.S. Food and Drug Administration.
2	FDA label for approved acitretin from the official website of the U.S. Food and Drug Administration.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.